Article Versions Notes

Sugiura A, Joshita S, Yamashita Y, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Wada S, Mori H, Shibata S, et al. Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases. Biomedicines. 2020; 8(4):74. https://doi.org/10.3390/biomedicines8040074

Sugiura, Ayumi, Satoru Joshita, Yuki Yamashita, Tomoo Yamazaki, Naoyuki Fujimori, Takefumi Kimura, Akihiro Matsumoto, Shuichi Wada, Hiromitsu Mori, Soichiro Shibata, and et al. 2020. "Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases" Biomedicines 8, no. 4: 74. https://doi.org/10.3390/biomedicines8040074

Sugiura, A., Joshita, S., Yamashita, Y., Yamazaki, T., Fujimori, N., Kimura, T., Matsumoto, A., Wada, S., Mori, H., Shibata, S., Yoshizawa, K., Morita, S., Furuta, K., Kamijo, A., Iijima, A., Kako, S., Maruyama, A., Kobayashi, M., Komatsu, M., ... Umemura, T. (2020). Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases. Biomedicines, 8(4), 74. https://doi.org/10.3390/biomedicines8040074